[HTML][HTML] The management of desmoid tumours: a joint global consensus-based guideline approach for adult and paediatric patients

B Alman, S Attia, C Baumgarten, C Benson… - European Journal of …, 2020 - Elsevier
Desmoid tumor (DT; other synonymously used terms: Desmoid-type fibromatosis,
aggressive fibromatosis) is a rare and locally aggressive monoclonal, fibroblastic …

Surgery versus radiation therapy for patients with aggressive fibromatosis or desmoid tumors: a comparative review of 22 articles

JJ Nuyttens, PF Rust, CR Thomas Jr, AT Turrisi III - Cancer, 2000 - Wiley Online Library
BACKGROUND Desmoid tumors (aggressive fibromatoses) are benign neoplasms with high
rates of recurrence after surgery. Radiotherapy is sometimes reported to prevent …

A prognostic nomogram for prediction of recurrence in desmoid fibromatosis

AM Crago, B Denton, S Salas, A Dufresne… - Annals of …, 2013 - journals.lww.com
Objective: To construct a postoperative nomogram to estimate the risk of local recurrence for
patients with desmoid tumors. Background: The standard management of desmoid tumors is …

Desmoid tumor: prognostic factors and outcome after surgery, radiation therapy, or combined surgery and radiation therapy

MT Ballo, GK Zagars, A Pollack, PWT Pisters… - Journal of Clinical …, 1999 - ascopubs.org
PURPOSE: To evaluate the therapeutic value of resection and the potential benefits of and
indications for adjuvant and definitive radiation therapy for desmoid tumors. MATERIALS …

Quality of surgery and outcome in extra-abdominal aggressive fibromatosis: a series of patients surgically treated at a single institution

A Gronchi, PG Casali, L Mariani, S Lo Vullo… - Journal of Clinical …, 2003 - ascopubs.org
Purpose: To explore prognostic factors in surgically treated aggressive fibromatosis (extra-
abdominal desmoid tumor). Patients and Methods: A total of 203 consecutive patients …

Extra-abdominal primary fibromatosis: aggressive management could be avoided in a subgroup of patients

S Bonvalot, H Eldweny, V Haddad, F Rimareix… - European Journal of …, 2008 - Elsevier
OBJECTIVE: To evaluate the impact of surgery as first-line treatment on event-free survival
(EFS) of primary aggressive fibromatosis. PATIENTS AND METHODS: Treatments were …

Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)

S Tejpar, F Nollet, C Li, JS Wunder, G Michils, P dal Cin… - Oncogene, 1999 - nature.com
Aggressive fibromatosis (also called desmoid tumor) occurs as a sporadic lesion or as part
of Familial Adenomatous Polyposis, which is caused by germ line mutations in the …

Desmoids in familial adenomatous polyposis

SK Clark, RKS Phillips - British journal of surgery, 1996 - Wiley Online Library
Clinical desmoid disease affects approximately 10 per cent of patients with familial
adenomatous polyposis (FAP); the subclinical rate is unknown. Desmoids are probably …

Low‐dose chemotherapy with methotrexate and vinblastine for patients with advanced aggressive fibromatosis

A Azzarelli, A Gronchi, R Bertulli… - … Journal of the …, 2001 - Wiley Online Library
Abstract BACKGROUND This Phase II study was undertaken to assess the activity of
methotrexate plus vinblastine in the treatment of patients with inoperable aggressive …

Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series

JT Mullen, TF DeLaney, WK Kobayashi… - Annals of surgical …, 2012 - Springer
Background Desmoid tumors are rare and exhibit a highly unpredictable natural history. We
sought to analyze prognostic factors associated with recurrence in a large single-institution …